An Effectiveness, Safety and Quality of Life Measures With Hydromorphone HCL, Dilaudid CR (Controlled Release)

Clinical trial NCT00399048 · COMPLETED

Trial details

NCT number: NCT00399048
Sponsor: Alza Corporation, DE, USA
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Osteoarthritis, Knee Osteoarthritis, Hip

Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.